Image_2_Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.tiff by Biswas Neupane (2167513)

“…We further found that IL-17A inhibited IFN-α2 production by modulating the expression of Interferon Regulatory Factor-5 (IRF-5), IRF-7, IFN-stimulated gene 49 (ISG-49), and Mx1 expression during CHIKV infection. …”

Image_1_Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.tiff by Biswas Neupane (2167513)

“…We further found that IL-17A inhibited IFN-α2 production by modulating the expression of Interferon Regulatory Factor-5 (IRF-5), IRF-7, IFN-stimulated gene 49 (ISG-49), and Mx1 expression during CHIKV infection. …”

DataSheet_5_A causal examination of the correlation between hormonal and reproductive factors and low back pain.pdf by Dafu Chen (291913)

Image_5_Integrated plasma metabolomic and cytokine analysis reveals a distinct immunometabolic signature in atopic dermatitis.jpeg by Emily Z. Ma (18157630)

“…</p>Design<p>This study collected plasma from 20 atopic dermatitis with moderate-to-severe itch (score of ≥5 on the itch Numeric Rating Scale and IGA score ≥3) and 24 healthy control patients. …”

Inhibition of the TrkA signaling protected mice from lethal A/PR8 infection. by Vikram Verma (13822961)

PowerPoint Slides for: Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients by Sprague S.M. (2884187)

“…Populations were compared using a mixed-effects model to obtain the least squares mean change in iPTH from baseline to Week 52. …”

Mean thickness of retinal layers among genotypic classes at each QTL. by Kelly E. O'Quin (255711)

“…The distributions of mean OPL, GCL, and ONL thickness indicate that cavefish alleles are inherited dominantly and contribute to a clear decrease in retinal thickness. …”

The expression of IL-18 in human primary keratinocytes and PBMCs after exposure to <i>S. globosa</i> in vitro. by Henan Si (21512689)

Primers used for 47S rRNA qPCRs. by Michael R. van Gerven (16764526)

“…In contrast to other pediatric cancer where <i>ATRX</i> point mutations are most frequent, multi-exon deletions (MEDs) are the most frequent type of <i>ATRX</i> aberrations in neuroblastoma. 75% of these MEDs are predicted to produce in-frame fusion proteins, suggesting a potential gain-of-function effect compared to nonsense mutations. …”

Primers used for validation of patient-derived and isogenic models. by Michael R. van Gerven (16764526)

Generation and validation of ATRX aberrant isogenic cell lines/tumoroids. by Michael R. van Gerven (16764526)

The expression of caspase-1 in PBMCs after exposure to <i>S. globosa</i> in vitro. by Henan Si (21512689)

DRP2B is partially required for flg22-induced endocytosis of FLS2. by John M. Smith (676719)

“…All experiments were repeated at least three independent times with similar results. Values are mean ± SE. Statistical analysis was done as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004578#ppat-1004578-g001" target="_blank">Fig. 1</a>.…”

Overlap of differentially expressed genes (DEGs) and gene ontology (GO) analysis identifies two distinct gene expression patterns within <i>ATRX</i> aberrant neuroblastoma. by Michael R. van Gerven (16764526)

Characterization of neuroblastoma cell lines with ATRX multi-exon deletions. by Michael R. van Gerven (16764526)

Fig 4 - by Torsten Schober (20485754)

Participant inclusion flowchart. by Shakila Meshkat (12360623)

“…In both unadjusted and adjusted models, participants with depressive symptoms had lower odds of FS (aOR = 0.347, 95% CI: 0.307,0.391, p<0.001). Moreover, in both unadjusted and adjusted models, for each 1-point increase in cognitive-affective (aOR = 0.850, 95% CI = 0.836,0.864, p <0.001) and somatic symptoms (aOR = 0.847, 95% CI = 0.831,0.863, p <0.001), odds of high FS decreased correspondingly. …”

Demographics of study sample. by Shakila Meshkat (12360623)

“…In both unadjusted and adjusted models, participants with depressive symptoms had lower odds of FS (aOR = 0.347, 95% CI: 0.307,0.391, p<0.001). Moreover, in both unadjusted and adjusted models, for each 1-point increase in cognitive-affective (aOR = 0.850, 95% CI = 0.836,0.864, p <0.001) and somatic symptoms (aOR = 0.847, 95% CI = 0.831,0.863, p <0.001), odds of high FS decreased correspondingly. …”

Antibodies used for western blotting and for immune fluorescence. by Michael R. van Gerven (16764526)

Sequences of sgRNAs used to make isogenic knock-out and ATRX MEDs. by Michael R. van Gerven (16764526)